FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Monica Naujokas

Research Profile

Chemicals & Drugs

Anatomy

Phenomena

Phosphorylation

Physiology

Co-author Network

Publications

TOP 3
Jennifer F Knight; Robert Lesurf; William J Muller; Anna Marie Mulligan; Monica A Naujokas; Irene L Andrulis; Robert Cardiff; Naila Chughtai; Ryan R Davis; Jeff P Gregg; Michael T Hallett; Jason I Herschkowitz; Dushanthi Pinnaduwage; Aleix Prat; Sadiq M I Saleh; Hong Zhao; Dongmei Zuo; Morag Park
Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer.
Charles V Rajadurai; Matthew Stuible; Michel L Tremblay; Richard Vaillancourt; Kossay Zaoui; Dongmei Zuo; Serhiy Havrylov; Monica A Naujokas; Morag Park
Met receptor tyrosine kinase signals through a cortactin-Gab1 scaffold complex, to mediate invadopodia.
Grigorios N Paliouras; Monica A Naujokas; Morag Park
Pak4, a novel Gab1 binding partner, modulates cell migration and invasion by the Met receptor.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Monica Naujokas (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jennifer F Knight; Robert Lesurf; William J Muller; Anna Marie Mulligan; Monica A Naujokas; Irene L Andrulis; Robert Cardiff; Naila Chughtai; Ryan R Davis; Jeff P Gregg; Michael T Hallett; Jason I Herschkowitz; Dushanthi Pinnaduwage; Aleix Prat; Sadiq M I Saleh; Hong Zhao; Dongmei Zuo; Morag Park
Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer.
Proceedings of the National Academy of Sciences of the United States of America 2013;110(14):E1301-10.
2012: Charles V Rajadurai; Matthew Stuible; Michel L Tremblay; Richard Vaillancourt; Kossay Zaoui; Dongmei Zuo; Serhiy Havrylov; Monica A Naujokas; Morag Park
Met receptor tyrosine kinase signals through a cortactin-Gab1 scaffold complex, to mediate invadopodia.
Journal of cell science 2012;125(Pt 12):2940-53.
2009: Grigorios N Paliouras; Monica A Naujokas; Morag Park
Pak4, a novel Gab1 binding partner, modulates cell migration and invasion by the Met receptor.
Molecular and cellular biology 2009;29(11):3018-32.
2008: Melanie M Frigault; Monica A Naujokas; Morag Park
Gab2 requires membrane targeting and the Met binding motif to promote lamellipodia, cell scatter, and epithelial morphogenesis downstream from the Met receptor.
Journal of cellular physiology 2008;214(3):694-705.
2007: H H L Mak; Pascal Peschard; Tong Lin; Monica A Naujokas; Dongmei Zuo; Morag Park
Oncogenic activation of the Met receptor tyrosine kinase fusion protein, Tpr-Met, involves exclusion from the endocytic degradative pathway.
Oncogene 2007;26(51):7213-21.
2005: Jasmine V Abella; Pascal Peschard; Monica A Naujokas; Tong Lin; Caroline Saucier; Sylvie Urbé; Morag Park
Met/Hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylation.
Molecular and cellular biology 2005;25(21):9632-45.
2005: Hanane Khoury; Monica A Naujokas; Dongmei Zuo; Veena Sangwan; Melanie M Frigault; Stephanie Petkiewicz; David Dankort; William J Muller; Morag Park
HGF converts ErbB2/Neu epithelial morphogenesis to cell invasion.
Molecular biology of the cell 2005;16(2):550-61.
2004: Caroline Saucier; Hanane Khoury; Ka-Man Venus Lai; Pascal Peschard; David Dankort; Monica A Naujokas; Jocelyn Holash; George D Yancopoulos; William J Muller; Tony Pawson; Morag Park
The Shc adaptor protein is critical for VEGF induction by Met/HGF and ErbB2 receptors and for early onset of tumor angiogenesis.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(8):2345-50.
2003: Christiane R Maroun; Monica A Naujokas; Morag Park
Membrane targeting of Grb2-associated binder-1 (Gab1) scaffolding protein through Src myristoylation sequence substitutes for Gab1 pleckstrin homology domain and switches an epidermal growth factor response to an invasive morphogenic program.
Molecular biology of the cell 2003;14(4):1691-708.
2002: Louie Lamorte; Sonia Rodrigues; Monica A Naujokas; Morag Park
Crk synergizes with epidermal growth factor for epithelial invasion and morphogenesis and is required for the met morphogenic program.
The Journal of biological chemistry 2002;277(40):37904-11.
2002: Lisa S Lock; Christiane R Maroun; Monica A Naujokas; Morag Park
Distinct recruitment and function of Gab1 and Gab2 in Met receptor-mediated epithelial morphogenesis.
Molecular biology of the cell 2002;13(6):2132-46.
2002: Louie Lamorte; Isabelle Royal; Monica A Naujokas; Morag Park
Crk adapter proteins promote an epithelial-mesenchymal-like transition and are required for HGF-mediated cell spreading and breakdown of epithelial adherens junctions.
Molecular biology of the cell 2002;13(5):1449-61.
2002: Caroline Saucier; Vasilios Papavasiliou; Alexander Palazzo; Monica A Naujokas; Richard Kremer; Morag Park
Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis.
Oncogene 2002;21(12):1800-11.
2001: Pascal Peschard; TM Fournier; Louie Lamorte; Monica A Naujokas; Hamid Band; Wallace Y Langdon; Morag Park
Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein.
Molecular cell 2001;8(5):995-1004.
2001: H Khoury; David Dankort; S Sadekova; Monica A Naujokas; William J Muller; Morag Park
Distinct tyrosine autophosphorylation sites mediate induction of epithelial mesenchymal like transition by an activated ErbB-2/Neu receptor.
Oncogene 2001;20(7):788-99.
2000: Christiane R Maroun; Monica A Naujokas; Marina Holgado-Madruga; Albert J Wong; Morag Park
The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase.
Molecular and cellular biology 2000;20(22):8513-25.
2000: Lisa S Lock; Isabelle Royal; Monica A Naujokas; Morag Park
Identification of an atypical Grb2 carboxyl-terminal SH3 domain binding site in Gab docking proteins reveals Grb2-dependent and -independent recruitment of Gab1 to receptor tyrosine kinases.
The Journal of biological chemistry 2000;275(40):31536-45.
2000: Darren Kamikura; Hanane Khoury; Christiane R Maroun; Monica A Naujokas; Morag Park
Enhanced transformation by a plasma membrane-associated met oncoprotein: activation of a phosphoinositide 3'-kinase-dependent autocrine loop involving hyaluronic acid and CD44.
Molecular and cellular biology 2000;20(10):3482-96.
1999: Christiane R Maroun; Moscatello David; Monica A Naujokas; Marina Holgado-Madruga; Albert J Wong; Morag Park
A conserved inositol phospholipid binding site within the pleckstrin homology domain of the Gab1 docking protein is required for epithelial morphogenesis.
The Journal of biological chemistry 1999;274(44):31719-26.
1999: Christiane R Maroun; Marina Holgado-Madruga; Isabelle Royal; Monica A Naujokas; TM Fournier; Albert J Wong; Morag Park
The Gab1 PH domain is required for localization of Gab1 at sites of cell-cell contact and epithelial morphogenesis downstream from the met receptor tyrosine kinase.
Molecular and cellular biology 1999;19(3):1784-99.
1998: J C Lin; Monica A Naujokas; H Zhu; S Nolet; Morag Park
Intron-exon structure of the MET gene and cloning of an alternatively-spliced Met isoform reveals frequent exon-skipping of a single large internal exon.
Oncogene 1998;16(7):833-42.
1996: Elizabeth D Fixman; TM Fournier; Darren Kamikura; Monica A Naujokas; Morag Park
Pathways downstream of Shc and Grb2 are required for cell transformation by the tpr-Met oncoprotein.
The Journal of biological chemistry 1996;271(22):13116-22.
1996: Darren Kamikura; Monica A Naujokas; Morag Park
Identification of tyrosine 489 in the carboxy terminus of the Tpr-Met oncoprotein as a major site of autophosphorylation.
Biochemistry 1996;35(3):1010-7.
1995: Elizabeth D Fixman; Monica A Naujokas; G A Rodrigues; M F Moran; Morag Park
Efficient cell transformation by the Tpr-Met oncoprotein is dependent upon tyrosine 489 in the carboxy-terminus.
Oncogene 1995;10(2):237-49.
1994: H Zhu; Monica A Naujokas; Elizabeth D Fixman; K Torossian; Morag Park
Tyrosine 1356 in the carboxyl-terminal tail of the HGF/SF receptor is essential for the transduction of signals for cell motility and morphogenesis.
The Journal of biological chemistry 1994;269(47):29943-8.
1994: H Zhu; Monica A Naujokas; Morag Park
Receptor chimeras indicate that the met tyrosine kinase mediates the motility and morphogenic responses of hepatocyte growth/scatter factor.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1994;5(4):359-66.
1991: G A Rodrigues; Monica A Naujokas; Morag Park
Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing.
Molecular and cellular biology 1991;11(6):2962-70.
1989: E R Bennett; Monica A Naujokas; John A Hassell
Requirements for species-specific papovavirus DNA replication.
Journal of virology 1989;63(12):5371-85.
1984: William J Muller; Monica A Naujokas; John A Hassell
Isolation of large T antigen-producing mouse cell lines capable of supporting replication of polyomavirus-plasmid recombinants.
Molecular and cellular biology 1984;4(11):2406-12.
1984: M S Featherstone; Monica A Naujokas; B J Pomerantz; John A Hassell
A plasmid vehicle suitable for the molecular cloning and characterization of mammalian promoters.
Nucleic acids research 1984;12(18):7235-49.
1983: B J Pomerantz; Monica A Naujokas; John A Hassell
Homologous recombination between transfected DNAs.
Molecular and cellular biology 1983;3(9):1680-5.
1983: William J Muller; Monica A Naujokas; John A Hassell
Polyomavirus-plasmid recombinants capable of replicating have an enhanced transforming potential.
Molecular and cellular biology 1983;3(9):1670-4.